Neurocrine Biosciences Inc
Biological Products, (No Diagnostic Substances)
- Revenue, 2025
- $2.86B
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Institutional holders
- 775 at 30 Jun 2026 (699 the quarter before)
- SEC number
- 914475
- LEI
- 549300FECER0XBN49756
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026
Neurocrine Biosciences Inc is an American biopharmaceutical company in biotechnology, headquartered in San Diego, founded in 1992.
Source: Wikidata
Source: SEC EDGAR
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.